dacarbazine and Agnogenic Myeloid Metaplasia

dacarbazine has been researched along with Agnogenic Myeloid Metaplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Demir, I; Gunes, AK; Pehlivan, M	1

Other Studies

1 other study(ies) available for dacarbazine and Agnogenic Myeloid Metaplasia

Article	Year
Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:2 Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Nivolumab; Positron-Emission Tomography; Primary Myelofibrosis; Stem Cell Transplantation; Treatment Outcome; Vinblastine	2021

Article

Year

Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:2

Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoproliferative Disorders; Nivolumab; Positron-Emission Tomography; Primary Myelofibrosis; Stem Cell Transplantation; Treatment Outcome; Vinblastine

2021